In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin

Table 3

Zeta potential and polydispersity index.

Sr. number	Formulation	Zeta potential	Polydispersity index	Particle size (m)
1	NA2	−31.12	0.319 ± 0.052	7.972 ± 0.019
2	NB2	−29.67	0.263 ± 0.039	7.099 ± 0.041
3	NC2	−24.93	0.233 ± 0.091	4.674 ± 0.028
4	ND2	−26.62	0.279 ± 0.044	4.449 ± 0.070